Atlas Biologicals Revenue and Competitors
Estimated Revenue & Valuation
- Atlas Biologicals's estimated annual revenue is currently $1.4M per year.
- Atlas Biologicals's estimated revenue per employee is $155,000
Employee Data
- Atlas Biologicals has 9 Employees.
- Atlas Biologicals grew their employee count by 0% last year.
Atlas Biologicals's People
Name | Title | Email/Phone |
---|---|---|
1 | Owner | Reveal Email/Phone |
2 | Director Operations | Reveal Email/Phone |
3 | National Account Sales Manager | Reveal Email/Phone |
Atlas Biologicals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | 0% | N/A | N/A |
#2 | $2.8M | 18 | 13% | N/A | N/A |
#3 | $70.2M | 453 | -1% | N/A | N/A |
#4 | $1.6M | 10 | -66% | N/A | N/A |
#5 | $3.7M | 24 | -8% | N/A | N/A |
#6 | $2.9M | 37 | 28% | N/A | N/A |
#7 | $3.1M | 20 | 25% | N/A | N/A |
#8 | $2.5M | 16 | -20% | N/A | N/A |
#9 | $9.1M | 59 | 0% | N/A | N/A |
#10 | $4.2M | 27 | -7% | N/A | N/A |
What Is Atlas Biologicals?
Utilizing 30 years of experience, Atlas develops and provides high quality bovine serum used in biomanufacturing, cell culture, biopharmaceutical manufacturing, life science research, medical devices, and diagnostics. Our focus is on the entire process from farm to bottle ensuring traceability and manufacturing standards. We specialize in an alternative FBS called EquaFetal that provides similar results at a fraction of the cost. Our proprietary collection methods are designed to reduce variability typically seen with FBS, providing you with reproducible results. We would love to be your trusted serum source. Get your FREE samples today!
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | 0% | N/A |
#2 | $0.7M | 9 | 0% | N/A |
#3 | $0.7M | 9 | 0% | N/A |
#4 | $1.5M | 9 | -86% | N/A |
#5 | $0.7M | 9 | 50% | N/A |